NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

RecruitingN/A

Sponsor: Ruijin Hospital

Conditions: IgA Nephropathy

Countries: China

1. Establish an IgAN cohort collaboration group and expert committee to carry out registration research. 2. Construct IgAN structured data set standards, formulate structured data collection templates of diagnosis and treatment , and establish multi-center data integration systems on this basis. 3. Establish a standardized IgAN database for combined Hospital Information System and the big data platform of the Medical Federation. 4. Develop IgAN database managements and open standards for data sharing, and carry out high-quality clinical or basic research.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. No age limit, no gender limit;
2. Kidney biopsy confirmed primary IgA nephropathy;
3. Sign the informed consent form voluntarily

Exclusion Criteria:

1. IgA nephropathy is secondary to systemic diseases such as systemic lupus erythematosus and allergic purpura;
2. IgAN is clinically diagnosed but not confirmed by pathology;
3. The patient refuses to participate;
4. Patients judged by other investigators to be unsuitable for inclusion in the study.

Locations (1)

Shanghai, Shanghai Municipality, China